[HTML][HTML] 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - ncbi.nlm.nih.gov
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Immunosenescence and human vaccine immune responses
SN Crooke, IG Ovsyannikova, GA Poland… - Immunity & …, 2019 - Springer
The age-related dysregulation and decline of the immune system—collectively termed
“immunosenescence”—has been generally associated with an increased susceptibility to …
“immunosenescence”—has been generally associated with an increased susceptibility to …
[HTML][HTML] Pneumococcal vaccine for adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023
M Kobayashi - MMWR. Recommendations and Reports, 2023 - cdc.gov
This report compiles and summarizes all published recommendations from CDC's Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
[HTML][HTML] Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe
G Hanquet, P Krizova, T Dalby… - Emerging infectious …, 2022 - ncbi.nlm.nih.gov
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal
conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) …
conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) …
[HTML][HTML] A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal …
HL Platt, JF Cardona, M Haranaka, HI Schwartz… - Vaccine, 2022 - Elsevier
Abstract Background Pneumococcal conjugate vaccines (PCVs) have greatly reduced the
incidence of pneumococcal disease, yet unmet medical need remains due to increased …
incidence of pneumococcal disease, yet unmet medical need remains due to increased …
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination
G Hanquet, P Krizova, P Valentiner-Branth… - Thorax, 2019 - thorax.bmj.com
Background Pneumococcal conjugate vaccines (PCVs) have the potential to prevent
pneumococcal disease through direct and indirect protection. This multicentre European …
pneumococcal disease through direct and indirect protection. This multicentre European …
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2024
Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
[HTML][HTML] Fostering healthy aging: the interdependency of infections, immunity and frailty
DL Vetrano, F Triolo, S Maggi, R Malley… - Ageing research …, 2021 - Elsevier
Untangling the interdependency of infections, immunity and frailty may help to clarify their
roles in the maintenance of health in aging individuals, and the recent COVID-19 pandemic …
roles in the maintenance of health in aging individuals, and the recent COVID-19 pandemic …
Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives
A Wagner, B Weinberger - Frontiers in immunology, 2020 - frontiersin.org
Infectious diseases are a major cause for morbidity and mortality in the older population.
Demographic changes will lead to increasing numbers of older persons over the next …
Demographic changes will lead to increasing numbers of older persons over the next …